TY - JOUR
T1 - Establishing the cascade of care for patients with tuberculous meningitis
AU - Tuberculous Meningitis International Research Consortium
AU - Imran, Darma
AU - Hill, Philip C.
AU - McKnight, Jacob
AU - van Crevel, Reinout
N1 - Funding Information:
Grant information: DI and RvC are supported for research in TB meningitis by the Medical Research Council UK, High Dose Oral Rifampicin to Improve Survival from Adult TB Meningitis - (HARVEST) Trial [MR/S004963/1], and National Institute of Health for a project “Using Tryptophan Metabolism and Response to Corticosteroids to Define New Therapeutic Targets for Tuberculosis Meningitis: Integration of Large Scale Clinical, Metabolomic, and Genomic Data” [R01AI145781]. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This work was supported by the Wellcome Trust through funding to the Tuberculous Meningitis International Research Consortium.
Funding Information:
DI and RvC are supported for research in TB meningitis by the Medical Research Council UK, High Dose Oral Rifampicin to Improve Survival from Adult TB Meningitis - (HARVEST) Trial [MR/S004963/1], and National Institute of Health for a project ?Using Tryptophan Metabolism and Response to Corticosteroids to Define New Therapeutic Targets for Tuberculosis Meningitis: Integration of Large Scale Clinical, Metabolomic, and Genomic Data? [R01AI145781]. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This work was supported by the Wellcome Trust through funding to the Tuberculous Meningitis International Research Consortium.
Publisher Copyright:
© 2020 Imran D et al.
PY - 2020/1/1
Y1 - 2020/1/1
N2 - Meningitis is a relatively rare form of tuberculosis, but it carries a high mortality rate, reaching 50% in some settings, with higher rates among patients with HIV co-infection and those with drug-resistant disease. Most studies of tuberculosis meningitis (TBM) tend to focus on better diagnosis, drug treatment and supportive care for patients in hospital. However, there is significant variability in mortality between settings, which may be due to specific variation in the availability and quality of health care services, both prior to, during, and after hospitalization. Such variations have not been studied thoroughly, and we therefore present a theoretical framework that may help to identify where efforts should be focused in providing optimal services for TBM patients. As a first step, we propose an adjusted cascade of care for TBM and patient pathway studies that might help identify factors that account for losses and delays across the cascade. Many of the possible gaps in the TBM cascade are related to health systems factors; we have selected nine domains and provide relevant examples of systems factors for TBM for each of these domains that could be the basis for a health needs assessment to address such gaps. Finally, we suggest some immediate action that could be taken to help make improvements in services. Our theoretical framework will hopefully lead to more health system research and improved care for patients suffering from this most dangerous form of tuberculosis.
AB - Meningitis is a relatively rare form of tuberculosis, but it carries a high mortality rate, reaching 50% in some settings, with higher rates among patients with HIV co-infection and those with drug-resistant disease. Most studies of tuberculosis meningitis (TBM) tend to focus on better diagnosis, drug treatment and supportive care for patients in hospital. However, there is significant variability in mortality between settings, which may be due to specific variation in the availability and quality of health care services, both prior to, during, and after hospitalization. Such variations have not been studied thoroughly, and we therefore present a theoretical framework that may help to identify where efforts should be focused in providing optimal services for TBM patients. As a first step, we propose an adjusted cascade of care for TBM and patient pathway studies that might help identify factors that account for losses and delays across the cascade. Many of the possible gaps in the TBM cascade are related to health systems factors; we have selected nine domains and provide relevant examples of systems factors for TBM for each of these domains that could be the basis for a health needs assessment to address such gaps. Finally, we suggest some immediate action that could be taken to help make improvements in services. Our theoretical framework will hopefully lead to more health system research and improved care for patients suffering from this most dangerous form of tuberculosis.
KW - Cascade of care
KW - Health systems
KW - Meningitis
KW - Patient pathway analysis
KW - Tuberculosis
UR - http://www.scopus.com/inward/record.url?scp=85083651079&partnerID=8YFLogxK
U2 - 10.12688/wellcomeopenres.15515.1
DO - 10.12688/wellcomeopenres.15515.1
M3 - Review article
AN - SCOPUS:85083651079
SN - 2398-502X
VL - 4
JO - Wellcome Open Research
JF - Wellcome Open Research
M1 - 177
ER -